60 DEGREES PHARMACEUTICALS, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-2.3M | $-2.1M | $-1.4M | $-2.3M | $-1.7M | $-1.9M | $-2.0M | $-2.2M |
| Depreciation & Amortization | $17.0K | $16.7K | $15.2K | $12.2K | $9.2K | $6.7K | $5.4K | $4.3K |
| Depreciation | $17.0K | $16.7K | $15.2K | $12.2K | $9.2K | $6.7K | $5.4K | $4.3K |
| Amortization | $13.9K | $9.2K | $8.4K | $10.6K | $10.4K | $10.1K | $10.5K | $10.3K |
| Stock-Based Compensation | — | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-2.2M | $-2.7M | $-1.7M | $-2.1M | $-1.5M | $-1.6M | $-1.6M | $-1.7M |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | $30.0K | $79.9K | $10.0K | $47.3K | $2.7K | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-86.0K | $1.2M | $-1.4M | $-25.5K | $-51.7K | $1.7M | $-2.1K | $-1.7M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $0 | $3.4M | $458.6K | $4.3M | $0 | $1.7M | $973 | $5.2M |
| Net Change in Cash | $-2.3M | $1.8M | $-2.6M | $2.1M | $-1.5M | $1.8M | $-1.6M | $1.7M |
| Free Cash Flow | $-2.2M | $-2.8M | $-1.8M | $-2.1M | $-1.5M | $-1.6M | — | — |